He aha ʻo Ipilimumab: Nā hoʻohana, ka nui o ka lāʻau, nā hopena ʻaoʻao a me nā mea hou aku

He lāʻau lapaʻau immunotherapy ikaika ʻo Ipilimumab e kōkua ana i kāu ʻōnaehana pale e hakakā i kekahi mau ʻano maʻi maʻi maikaʻi. Hāʻawi ʻia ma o ka IV i loko o kahi haukapila a i ʻole ke keʻena lapaʻau, a hana ia ma ka wehe ʻana i nā kaʻa ma kāu ʻōnaehana pale i hiki iā ia ke ʻike a hoʻouka maikaʻi i nā pūnaewele maʻi maʻi.

Hōʻike kēia lāʻau lapaʻau i kahi holomua i ka mālama ʻana i ka maʻi maʻi, e hāʻawi ana i ka manaʻolana no nā maʻi me ka melanoma holomua a me nā maʻi maʻi koʻikoʻi ʻē aʻe. ʻOiai hiki iā ia ke hana i nā hopena ʻaoʻao nui, ua ʻike ka nui o nā maʻi i nā hoʻomaikaʻi nui i kā lākou hopena maʻi maʻi me kēia lapaʻau.

He aha ʻo Ipilimumab?

He ʻano immunotherapy ʻo Ipilimumab i kapa ʻia he mea hoʻopaʻa helu. He antibody i hana ʻia i ka hale hana e kuhikuhi ana i kahi protein i kapa ʻia ʻo CTLA-4 ma kāu mau pūnaewele pale.

E noʻonoʻo iā CTLA-4 ma ke ʻano he pedal brake ma kāu ʻōnaehana pale. Hoʻopunipuni pinepine nā pūnaewele maʻi maʻi i kou kino i ka mālama ʻana i kēia mau kaʻa, e pale ana i kāu ʻōnaehana pale mai ka hakakā ʻana i ka maʻi maʻi maikaʻi. Hoʻopaʻa ʻo Ipilimumab i kēia ʻōnaehana brake, e ʻae ana i kāu mau pūnaewele pale e hana ikaika i ka maʻi maʻi.

No kahi papa lāʻau lapaʻau i kapa ʻia he monoclonal antibodies kēia lāʻau lapaʻau. Ua hoʻolālā ʻia e hoʻohālike a hoʻonui i ka pane pale kūlohelohe o kou kino, akā ma ke ʻano i kuhikuhi ʻia a ikaika.

No ke aha e hoʻohana ʻia ai ʻo Ipilimumab?

Hoʻohana nui ʻia ʻo Ipilimumab e mālama i ka melanoma holomua, ke ʻano koʻikoʻi loa o ka maʻi maʻi ʻili. Ua ʻae ʻia nō hoʻi no ka mālama ʻana i kekahi mau ʻano maʻi maʻi māmā, maʻi maʻi kīkī, a me ka maʻi maʻi ate i nā kūlana kikoʻī.

Hiki i kāu kauka ke ʻōlelo aku iā ipilimumab inā ua laha kāu maʻi maʻi i nā ʻāpana ʻē aʻe o kou kino a i ʻole inā ʻaʻole i kūpono nā lāʻau lapaʻau ʻē aʻe. Hoʻohana pinepine ʻia ia i ka wā ʻaʻole hiki ke hana i ke ʻoki a i ʻole ma hope o ke ʻoki ʻana e kōkua i ka pale ʻana i ka maʻi maʻi mai ka hoʻi ʻana mai.

I kekahi manawa, hui pū ʻia ka ipilimumab me nā lāʻau immunotherapy ʻē aʻe e like me nivolumab e hana i kahi ala lapaʻau ikaika. E hoʻoholo kāu oncologist i ka hoʻolālā lapaʻau maikaʻi loa e pili ana i kāu ʻano maʻi maʻi, kona pae, a me kou olakino holoʻokoʻa.

Pehea e hana ai ʻo Ipilimumab?

Hana ʻo Ipilimumab ma ka pale ʻana i kahi protein checkpoint i kapa ʻia ʻo CTLA-4 e mālama maʻamau i kāu ʻōnaehana pale i ka nānā. Ua manaʻo ʻia he ʻano ikaika a ikaika o ka mālama ʻana i ka maʻi maʻi.

Ke ulu ka maʻi maʻi, ʻike pinepine ia i nā ala e hūnā ai mai kāu ʻōnaehana pale a i ʻole e hoʻopau i nā hiki kūlohelohe o kou kino e hakakā i ka maʻi maʻi. ʻO CTLA-4 kekahi o nā mīkini e hoʻohana ai ka maʻi maʻi e kāohi i kāu pane immune.

Ma ka pale ʻana iā CTLA-4, lawe maoli ʻo ipilimumab i nā laka palekana mai kāu ʻōnaehana pale. Hāʻawi kēia i kāu mau T-cell, ʻo ia nā cell immune kūikawā, e lilo i mea ikaika a ikaika i ka hoʻouka ʻana i nā cell maʻi maʻi ma kou kino.

ʻAʻole pepehi pololei ka lāʻau lapaʻau i nā cell maʻi maʻi e like me ka chemotherapy kuʻuna. Akā, hāʻawi ia i kou ʻōnaehana pale ponoʻī e hana i ka hāpai kaumaha, ʻo ia ke kumu i kapa ʻia ai ʻo immunotherapy.

Pehea wau e lawe ai iā Ipilimumab?

Hāʻawi mau ʻia ʻo Ipilimumab ma ke ʻano he infusion intravenous i loko o ka haukapila a i ʻole ke kikowaena lapaʻau maʻi maʻi kūikawā. ʻAʻole hiki iā ʻoe ke lawe i kēia lāʻau ma ka home, a pono ia i ka mālama olakino.

Lawe maʻamau ka infusion ma kahi o 90 mau minuke, a e loaʻa iā ʻoe i kēlā me kēia 3 pule no ka huina o 4 mau maʻi. E nānā pono kāu hui mālama ola iā ʻoe i ka wā a ma hope o kēlā me kēia infusion no nā hopena koke.

Ma mua o kēlā me kēia lapaʻau, hiki iā ʻoe ke hāʻawi ʻia i nā lāʻau lapaʻau e kōkua i ka pale ʻana i nā hopena maʻi. ʻAʻole pono ʻoe e hoʻokē ʻai ma mua o ka infusion, akā ʻo ka ʻai ʻana i ka meaʻai māmā ma mua hiki ke kōkua iā ʻoe e ʻoluʻolu i ka wā o ka lapaʻau.

E nānā mau kāu hui lapaʻau i kāu hana koko e nānā i ke ʻano o ka pane ʻana o kou kino i ka lāʻau a e nānā i nā hopena ʻaoʻao e hopohopo ai. He mea nui e mālama i nā manawa a pau i hoʻonohonoho ʻia, ʻoiai inā maikaʻi kou manaʻo.

Pehea ka lōʻihi e lawe ai au i ka Ipilimumab?

ʻO ke ala lapaʻau maʻamau no ka ipilimumab he ʻehā mau lāʻau i hāʻawi ʻia ma luna o 12 pule. He ʻokoʻa kēia mai nā lāʻau lapaʻau maʻi maʻi ʻē aʻe e hoʻomau ana no nā mahina a i ʻole nā makahiki.

Ma hope o ka pau ʻana o nā lāʻau ʻehā mua, ʻaʻole ʻoe e loaʻa hou i ka ipilimumab ke ʻole e holomua kāu maʻi maʻi a hoʻoholo kāu kauka e pono paha ka lāʻau hou. Hiki i ka lāʻau lapaʻau ke hoʻomau i ka hana ʻana i loko o kāu ʻōnaehana no nā mahina a i ʻole nā makahiki ma hope o kāu lāʻau hope loa.

E nānā kāu oncologist i kāu holomua me nā scans maʻamau a me nā hoʻokolohua koko e ʻike i ka maikaʻi o ka hana ʻana o ka lāʻau. ʻIke kekahi poʻe maʻi i nā hoʻomaikaʻi i loko o kekahi mau mahina, ʻoiai ʻaʻole ʻike nā mea ʻē aʻe i nā pōmaikaʻi piha a hiki i kekahi mau mahina ma hope o ka pau ʻana o ka lāʻau.

Inā loaʻa iā ʻoe ka ipilimumab me nā lāʻau immunotherapy ʻē aʻe, ʻokoʻa paha kāu papa hana lapaʻau. E wehewehe kāu kauka i kāu hoʻolālā lapaʻau a me ka manawa.

He aha nā hopena ʻaoʻao o Ipilimumab?

Hiki i ka Ipilimumab ke hana i nā hopena ʻaoʻao koʻikoʻi no ka mea e hoʻāla ai i kāu ʻōnaehana pale, i kekahi manawa hiki ke hoʻouka i nā ʻiʻo olakino me nā cell maʻi maʻi. ʻO ka hapa nui o nā maʻi e ʻike i kekahi mau hopena ʻaoʻao, akā maʻamau lākou e mālama ʻia me ka mālama olakino kūpono.

ʻO nā hopena ʻaoʻao maʻamau āu e ʻike ai, ʻo ia ka luhi, ka maʻi maʻi, ka ʻili ʻili, a me ka nausea. Hiki ke ʻano mai ka maʻalahi a i ka koʻikoʻi a hiki ke koi i ka lāʻau me nā steroids a i ʻole nā lāʻau ʻē aʻe.

Eia nā hopena ʻaoʻao maʻamau e pili ana i nā maʻi he nui:

• Luhi a me ka nāwaliwali e mau ana no nā pule
• Pāpaʻa e hiki ke koʻikoʻi a hiki ke loaʻa ke koko
• Pāpaʻa ʻili, ʻū, a i ʻole ka pōʻeleʻele o ka ʻili
• ʻO ka luaʻi a me ka emi ʻana o ka ʻai
• ʻEha o ka ʻōpū a me ka ʻūlū
• ʻEha poʻo a me nā ʻeha ʻiʻo

He mau hōʻailona kēia e hōʻike ana e lilo ana kāu ʻōnaehana pale i ka hana, ʻo ia nō ka mea a mākou e makemake ai e hana no ka hana pono ʻana o ka lapaʻau.

Hiki ke loaʻa nā hopena ʻaoʻao koʻikoʻi ke hoʻouka kāu ʻōnaehana pale i nā ʻōkana olakino. Hiki ke koʻikoʻi kēia mau hopena ʻaoʻao e pili ana i ka pale ʻana, akā hiki ke hoʻohuli ʻia me ka lapaʻau wikiwiki.

Eia nā hopena ʻaoʻao koʻikoʻi e pono ai ka lāʻau lapaʻau koke:

• Pāpaʻa koʻikoʻi a i ʻole colitis e pili ana i kou ʻōpū
• Hoʻāhu o ke ake e hiki ke hoʻoulu i ka melemele o ka ʻili a i ʻole nā maka
• Hoʻāhu o ka māmā e hoʻoulu ana i ka pilikia o ka hanu a i ʻole ka ʻū mau
• Nā pilikia o ka ʻōpū hormone e pili ana i kou thyroid, pituitary, a i ʻole nā ʻōpū adrenal
• Nā hopena ʻili koʻikoʻi me ka ʻōhū a i ʻole ka ʻili
• Nā pilikia o ka ʻōnaehana nerve e hoʻoulu ana i ka huikau a i ʻole nā loli o ka ʻike

ʻOiai e kani ana kēia mau hopena ʻaoʻao koʻikoʻi, ua aʻo maikaʻi ʻia kāu hui lapaʻau e ʻike a mālama iā lākou me ka wikiwiki. ʻO ka hapa nui o nā maʻi e loaʻa ana i nā hopena ʻaoʻao koʻikoʻi e ola piha me ka lapaʻau kūpono.

ʻO nā hopena ʻaoʻao laha akā koʻikoʻi e pili ana i nā hopena maʻi maʻi koʻikoʻi i ka wā o ka hoʻokomo ʻana, nā pilikia o ka naʻau, a me ka hoʻāhu o ka puʻupaʻa. E nānā pono kāu hui mālama ola iā ʻoe no kēia mau mea a pau.

ʻO wai ka mea ʻaʻole pono e lawe iā Ipilimumab?

ʻAʻole kūpono ʻo Ipilimumab no nā mea a pau, a e loiloi pono kāu kauka inā ʻo ia ka lāʻau lapaʻau kūpono nāu. Hiki i kekahi mau maʻi olakino a i ʻole nā kūlana ke hoʻolilo i kēia lapaʻau i mea pilikia loa.

ʻAʻole pono ʻoe e loaʻa iā ipilimumab inā ua loaʻa iā ʻoe kahi hopena maʻi koʻikoʻi iā ia i ka wā ma mua a i ʻole inā loaʻa iā ʻoe kekahi mau maʻi autoimmune ikaika e hiki ke hoʻonui ʻia e ka hana ʻana o ka ʻōnaehana pale.

E mālama nui kāu kauka i ka ʻōlelo ʻana iā ipilimumab inā loaʻa iā ʻoe kēia mau maʻi:

• Nā maʻi autoimmune ikaika e like me ka rheumatoid arthritis a i ʻole lupus
• Maʻi ʻōpū mumū e like me ka maʻi ʻo Crohn a i ʻole ulcerative colitis
• Maʻi ate koʻikoʻi a i ʻole hepatitis ikaika
• Maʻi māmā koʻikoʻi a i ʻole nā pilikia hanu
• Hoʻololi ʻōkana hou
• Hāpai a hānai paha

ʻO ka loaʻa ʻana o kēia mau maʻi ʻaʻole ia e kāpae ʻakomi iā ʻoe mai ka mālama ʻana, akā pono kāu kauka e kaupaona i nā pōmaikaʻi kūpono e kūʻē i nā pilikia me ka akahele loa.

ʻAʻole ʻo ka makahiki wale nō ke kumu e pale ai iā ipilimumab, akā ʻoi aku ka nui o ka poʻe ʻelemakule i ka pilikia o kekahi mau hopena ʻaoʻao. ʻOi aku ka nui o kou olakino holoʻokoʻa a me ka hiki ke ʻae i ka mālama ʻana ma mua o kou makahiki.

Inoa Brand Ipilimumab

Kūʻai ʻia ʻo Ipilimumab ma lalo o ka inoa brand Yervoy. ʻO kēia wale nō ka inoa brand i loaʻa no kēia lāʻau lapaʻau ma ʻAmelika Hui Pū ʻIa.

Hana ʻia ʻo Yervoy e Bristol Myers Squibb a ʻo ia ka mea pale CTLA-4 checkpoint mua i ʻae ʻia e ka FDA. Ua loaʻa iā ia kāna ʻae mua i ka makahiki 2011 no ka mālama ʻana i ka melanoma holomua.

Ke loaʻa iā ʻoe kāu lapaʻau, e ʻike ʻoe iā "Yervoy" ma ka lepili lāʻau a me kāu mau moʻolelo lapaʻau. ʻAʻohe mana generic o ipilimumab i loaʻa i kēia manawa.

Nā Koho ʻē aʻe o Ipilimumab

Nui nā lāʻau lapaʻau immunotherapy ʻē aʻe e hana like me ipilimumab akā e kuhikuhi ana i nā protein checkpoint like ʻole. ʻO nā koho maʻamau ʻo nivolumab a me pembrolizumab, e ālai ana i kahi protein i kapa ʻia ʻo PD-1.

Hiki i kāu kauka ke noʻonoʻo i kēia mau koho ʻē aʻe inā ʻaʻole kūpono ka ipilimumab iā ʻoe a i ʻole inā ʻaʻole pane kāu maʻi kanesa iā ia. I kekahi manawa, hoʻohana ʻia kēia mau lāʻau lapaʻau me ka ipilimumab no nā hopena maikaʻi aʻe.

Eia nā koho nui e kūkākūkā ai kāu kauka:

• Nivolumab (Opdivo) - pale i ka PD-1 a hoʻohana pinepine ʻia me ka ipilimumab
• Pembrolizumab (Keytruda) - pale pū i ka PD-1 a hiki ke hoʻohana wale ʻia
• Atezolizumab (Tecentriq) - pale i ka protein PD-L1
• Dostarlimab (Jemperli) - he mea pale PD-1 hou no kekahi mau maʻi kanesa

Aia ke koho ma waena o kēia mau lāʻau lapaʻau i kāu ʻano maʻi kanesa, kona mau ʻano, a me kou olakino holoʻokoʻa. E kōkua kāu oncologist e hoʻoholo i ke koho e hāʻawi iā ʻoe i ka manawa maikaʻi loa o ka holomua.

Ua ʻoi aku ka maikaʻi o Ipilimumab ma mua o Nivolumab?

Hana ʻokoʻa ka Ipilimumab a me ka nivolumab a ʻoi aku ka maikaʻi ke hoʻohana pū ʻia ma mua o ka hoʻohālikelike ʻana i kekahi i kekahi. He mau lāʻau lapaʻau immunotherapy ikaika lāua ʻelua, akā ua manaʻo lākou i nā ʻāpana like ʻole o kāu ʻōnaehana pale.

ʻOi aku ka liʻiliʻi o nā hopena ʻaoʻao koʻikoʻi o ka Nivolumab ma mua o ka ipilimumab, akā hiki i ka ipilimumab ke hāʻawi i nā pane lōʻihi i kekahi poʻe maʻi. Ua hōʻike ka hui pū ʻana o nā lāʻau ʻelua i nā hopena maikaʻi loa i hoʻohālikelike ʻia me kekahi lāʻau i nā hoʻokolohua lapaʻau he nui.

E noʻonoʻo kāu kauka i nā mea he nui i ke koho ʻana ma waena o kēia mau lāʻau lapaʻau, me kāu ʻano maʻi kanesa, kona pae, kou olakino holoʻokoʻa, a me kou hiki ke ʻae i nā hopena ʻaoʻao. ʻAʻole maikaʻi loa kekahi lāʻau - pili ia i kou kūlana pilikino.

Nui nā maʻi i kēia manawa e loaʻa ana nā lāʻau lapaʻau ʻelua i hui pū ʻia ma ke ʻano he lāʻau hui pū, i lilo i ala lapaʻau maʻamau no nā ʻano maʻi kanesa holomua.

Nā nīnau i nīnau pinepine ʻia e pili ana iā Ipilimumab

He palekana anei ʻo Ipilimumab no ka poʻe me nā maʻi autoimmune?

Pono ka ipilimumab i ka mālama keu inā he maʻi autoimmune kou no ka mea hiki iā ia ke hoʻonui i kēia mau maʻi. E loiloi pono kāu kauka inā ʻoi aku ka maikaʻi ma mua o nā pilikia i kāu kūlana.

Ua loaʻa i kekahi poʻe maʻi me nā maʻi autoimmune i mālama maikaʻi ʻia ka ipilimumab, akā pono lākou i ka nānā pono ʻana a pono paha i nā lāʻau lapaʻau hou e mālama ai i nā hōʻailona o ko lākou maʻi autoimmune.

He aha kaʻu e hana ai inā ua hala au i kahi mahele o Ipilimumab?

No ka mea, hāʻawi ʻia ka ipilimumab i loko o kahi keʻena lapaʻau, hiki ke hala i kahi mahele ma muli o nā paio hoʻonohonoho a i ʻole nā kumu olakino. E kelepona koke i kāu hui oncology e hoʻonohonoho hou i kāu manawa.

E hoʻoholo kāu kauka i ke ala maikaʻi loa e hoʻomau ai i kāu papa hana lapaʻau. I ka hapanui o nā hihia, e loaʻa iā ʻoe ka mahele i hala i ka hiki wawe, a e hoʻoponopono ʻia nā mahele i koe e like me ia e mālama ai i ka manawa kūpono ma waena o nā lapaʻau.

He aha kaʻu e hana ai inā he hopena koʻikoʻi koʻu i ka Ipilimumab?

Inā loaʻa iā ʻoe ka maʻi maʻi koʻikoʻi, ka pilikia o ka hanu ʻana, nā hopena ʻili koʻikoʻi, a i ʻole nā ​​hōʻailona ʻē aʻe e pili ana ma hope o ka loaʻa ʻana o ka ipilimumab, e kelepona koke i kāu hui mālama ola a i ʻole e hele i ka lumi pilikia.

Mai kali e ʻike inā e hoʻomaikaʻi nā hōʻailona iā lākou iho. He mea nui ka mālama mua ʻana i nā hopena ʻaoʻao koʻikoʻi a hiki ke pale i nā pilikia koʻikoʻi. Loaʻa i kāu hui lapaʻau nā protocols kikoʻī no ka mālama ʻana i nā hopena ʻaoʻao immunotherapy.

I ka manawa hea e hiki ai iaʻu ke hooki i ka lawe ʻana i ka Ipilimumab?

ʻO ka lapaʻau ipilimumab maʻamau he ʻehā wale nō mau mahele i hāʻawi ʻia ma luna o 12 mau pule, no laila e hoʻopau maoli ka hapa nui o nā maʻi i kā lākou papa lapaʻau. E hoʻoholo kāu kauka inā pono ʻoe e hooki mua ma muli o nā hopena ʻaoʻao a i ʻole inā he mea pono nā mahele hou.

Ma hope o ka pau ʻana o ka lapaʻau ʻana, e hoʻomau ana kāu kauka i ka nānā ʻana iā ʻoe no ka pane ʻana i ka lapaʻau a me nā hopena ʻaoʻao i lohi. Hiki i ka lāʻau lapaʻau ke hoʻomau i ka hana ʻana i loko o kou kino no nā mahina ma hope o kāu mahele hope loa.

Hiki iaʻu ke lawe i nā lāʻau lapaʻau ʻē aʻe i ka wā e loaʻa ana iaʻu ka Ipilimumab?

Hiki iā ʻoe ke lawe i nā lāʻau lapaʻau he nui i ka wā e loaʻa ana iā ʻoe ka ipilimumab, akā hiki i kekahi ke launa pū me ka lapaʻau a i ʻole ke hoʻopilikia i kou ʻōnaehana pale. E hōʻike mau i kāu hui mālama ola e pili ana i nā lāʻau lapaʻau a pau, nā mea hoʻohui, a me nā huahana lāʻau lapaʻau āu e lawe nei.

Pono paha kāu kauka e hoʻoponopono i kekahi mau lāʻau lapaʻau, ʻoiai nā mea e pili ana i kou ʻōnaehana pale e like me nā steroids a i ʻole nā immunosuppressants. Mai hooki a hoʻomaka paha i nā lāʻau lapaʻau hou me ka ʻole e kūkākūkā mua me kāu hui oncology.